pab involved in exciting discovery, page-7

Further to the above Information/research by Voglio...
Here is more....(From Minomic's Official Site):

"Patrys’ previous collaboration with Professor Packer showed that PAT-SM6 detects specific changes in the proteins present on the surface of multiple myeloma cells, but not on normal cells. These cancer modified cells in the patients’ blood and urine are very rare in early stages of disease and their detection poses a “needle-in-a-haystack” challenge at both the research and clinical levels. Current diagnostic tests are not sensitive enough to detect these rare-event cells, resulting in an inefficient early detection and diagnosis of cancer and consequently poor prognosis.

Patrys CEO, Dr. Marie Roskrow, said: “Patrys is very proud to be part of this exciting and cutting-edge project and welcomes the opportunity to explore the innovative aspects of Patrys’ antibodies. The possibility to use Patrys’ antibodies as cancer diagnostics as well as therapeutics is very exciting and potentially brings additional opportunities and value to the Patrys’ pipeline.”

http://www.minomic.com/Post/i11

Cheers:))